Literature DB >> 28596451

Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke: The Framingham Study.

Hamidreza Saber1, Jayandra J Himali1, Alexa S Beiser1, Ashkan Shoamanesh1, Aleksandra Pikula1, Ronenn Roubenoff1, Jose R Romero1, Carlos S Kase1, Ramachandran S Vasan1, Sudha Seshadri2.   

Abstract

BACKGROUND AND
PURPOSE: Low insulin-like growth factor 1 (IGF-1) has been associated with increased risk of atherosclerosis and atrial fibrillation in cross-sectional studies. Yet, prospective data linking IGF-1 levels to the development of ischemic stroke remain inconclusive. We examined prospectively the association between serum IGF-1 levels and incident ischemic stroke.
METHODS: We measured serum IGF-1 levels in 757 elderly individuals (mean age 79±5, 62% women), free of prevalent stroke, from the Framingham original cohort participants at the 22nd examination cycle (1990-1994) and were followed up for the development of ischemic stroke. Cox models were used to relate IGF-1 levels to the risk for incident ischemic stroke, adjusted for potential confounders.
RESULTS: During a mean follow-up of 10.2 years, 99 individuals developed ischemic stroke. After adjustment for age, sex, and potential confounders, higher IGF-1 levels were associated with a lower risk of incident ischemic stroke, with subjects in the lowest quintile of IGF-1 levels having a 2.3-fold higher risk of incident ischemic stroke (95% confidence interval, 1.09-5.06; P=0.03) as compared with those in the top quintile. We observed an effect modification by diabetes mellitus and waist-hip ratio for the association between IGF-1 and ischemic stroke (P<0.1). In subgroup analyses, the effects were restricted to subjects with diabetics and those in top waist-hip ratio quartile, in whom each standard deviation increase in IGF-1 was associated with a 61% (hazard ratio, 0.39; 95% confidence interval, 0.20-0.78; P=0.007) and 41% (hazard ratio, 0.59; 95% confidence interval, 0.37-0.95; P=0.031) lower risk of incident ischemic stroke, respectively.
CONCLUSIONS: IGF-1 levels were inversely associated with ischemic stroke, especially among persons with insulin resistance.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  IGF-1; atrial fibrillation; insulin resistance; ischemic stroke; risk

Mesh:

Substances:

Year:  2017        PMID: 28596451      PMCID: PMC5505338          DOI: 10.1161/STROKEAHA.116.016563

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  36 in total

Review 1.  Insulin-like growth factor-1 as a vascular protective factor.

Authors:  Elena Conti; Cinzia Carrozza; Ettore Capoluongo; Massimo Volpe; Filippo Crea; Cecilia Zuppi; Felicita Andreotti
Journal:  Circulation       Date:  2004-10-12       Impact factor: 29.690

2.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

3.  Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?

Authors:  Mark O Goodarzi; Bruce M Psaty
Journal:  JAMA       Date:  2008-11-05       Impact factor: 56.272

4.  Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells.

Authors:  Guolian Li; Eugene J Barrett; Hong Wang; Weidong Chai; Zhenqi Liu
Journal:  Endocrinology       Date:  2005-08-11       Impact factor: 4.736

5.  Liposomal IGF-1 gene transfer modulates pro- and anti-inflammatory cytokine mRNA expression in the burn wound.

Authors:  M Spies; O Nesic; R E Barrow; J R Perez-Polo; D N Herndon
Journal:  Gene Ther       Date:  2001-09       Impact factor: 5.250

6.  Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study.

Authors:  Manjinder S Sandhu; Adrian H Heald; J Martin Gibson; J Kennedy Cruickshank; David B Dunger; Nicholas J Wareham
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

7.  Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.

Authors:  M Pfeifer; R Verhovec; B Zizek; J Prezelj; P Poredos; R N Clayton
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

8.  One-hour post-load plasma glucose and IGF-1 in hypertensive patients.

Authors:  Francesco Perticone; Angela Sciacqua; Eliezer J Tassone; Sofia Miceli; Raffaele Maio; Desirée Addesi; Tania Falbo; Franco Arturi; Giorgio Sesti
Journal:  Eur J Clin Invest       Date:  2012-10-18       Impact factor: 4.686

9.  Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes.

Authors:  A C Moses; S C Young; L A Morrow; M O'Brien; D R Clemmons
Journal:  Diabetes       Date:  1996-01       Impact factor: 9.461

10.  Positive association between circulating free insulin-like growth factor-1 levels and coronary flow reserve in arterial systemic hypertension.

Authors:  Maurizio Galderisi; Pio Caso; Silvana Cicala; Luigi De Simone; Michelangela Barbieri; Giovanni Vitale; Oreste de Divitiis; Giuseppe Paolisso
Journal:  Am J Hypertens       Date:  2002-09       Impact factor: 2.689

View more
  22 in total

1.  Differential Expression of Vascular Endothelial Growth Factor-A165 Isoforms Between Intracranial Atherosclerosis and Moyamoya Disease.

Authors:  Hao Jiang; Juan F Toscano; Michael Schiraldi; Shlee S Song; Konrad H Schlick; Oana M Dumitrascu; Raymond Liou; Patrick D Lyden; Jianwei Pan; Renya Zhan; Jeffrey L Saver; Nestor R Gonzalez
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-11-02       Impact factor: 2.136

Review 2.  IGF-1 and cardiovascular disease.

Authors:  Yusuke Higashi; Sandeep Gautam; Patrick Delafontaine; Sergiy Sukhanov
Journal:  Growth Horm IGF Res       Date:  2019-01-31       Impact factor: 2.372

3.  Central IGF-1 protects against features of cognitive and sensorimotor decline with aging in male mice.

Authors:  Gabriela E Farias Quipildor; Kai Mao; Zunju Hu; Ardijana Novaj; Min-Hui Cui; Maria Gulinello; Craig A Branch; Sriram Gubbi; Khushbu Patel; Douglas R Moellering; Stefano Tarantini; Tamas Kiss; Andriy Yabluchanskiy; Zoltan Ungvari; William E Sonntag; Derek M Huffman
Journal:  Geroscience       Date:  2019-05-10       Impact factor: 7.713

Review 4.  40 YEARS of IGF1: IGF1: the Jekyll and Hyde of the aging brain.

Authors:  Sriram Gubbi; Gabriela Farias Quipildor; Nir Barzilai; Derek M Huffman; Sofiya Milman
Journal:  J Mol Endocrinol       Date:  2018-05-08       Impact factor: 5.098

Review 5.  Association between insulin-like growth factor-1 and cardiovascular events: a systematic review and dose-response meta-analysis of cohort studies.

Authors:  T Li; Y Zhao; X Yang; Y Feng; Y Li; Y Wu; M Zhang; X Li; H Hu; J Zhang; L Yuan; Y Liu; X Sun; P Qin; C Chen; D Hu
Journal:  J Endocrinol Invest       Date:  2022-05-21       Impact factor: 4.256

6.  Protein Biomarkers and Risk of Atrial Fibrillation: The FHS.

Authors:  Laila Staerk; Sarah R Preis; Honghuang Lin; Steven A Lubitz; Patrick T Ellinor; Daniel Levy; Emelia J Benjamin; Ludovic Trinquart
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-01-15

7.  Insulin-like growth factor-I is required to maintain muscle volume in adult mice.

Authors:  Satoshi Nakamura; Yuiko Sato; Tami Kobayashi; Takatsugu Oike; Yosuke Kaneko; Kana Miyamoto; Atsushi Funayama; Akihito Oya; Toru Nishiwaki; Morio Matsumoto; Masaya Nakamura; Arihiko Kanaji; Takeshi Miyamoto
Journal:  J Bone Miner Metab       Date:  2018-10-15       Impact factor: 2.626

8.  Preclinical and clinical evidence of IGF-1 as a prognostic marker and acute intervention with ischemic stroke.

Authors:  Cellas A Hayes; M Noa Valcarcel-Ares; Nicole M Ashpole
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-24       Impact factor: 6.200

9.  Declining Levels and Bioavailability of IGF-I in Cardiovascular Aging Associate With QT Prolongation-Results From the 1946 British Birth Cohort.

Authors:  Christos Charalambous; James C Moon; Jeff M P Holly; Nishi Chaturvedi; Alun D Hughes; Gabriella Captur
Journal:  Front Cardiovasc Med       Date:  2022-04-22

10.  Insulin-Like Growth Factor-1 in Acute Ischemic Stroke.

Authors:  Hala Shaheen; Sayed Sobhy; Sherine El Mously; Manal Niazi; Mohammed Gomaa
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.